BioCentury
ARTICLE | Company News

Pfizer China GM Wu jumps to BeiGene

May 1, 2018 11:35 PM UTC

BeiGene Ltd. (NASDAQ:BGNE) hired Xiaobing Wu as general manager of China and president. He joins the Chinese bellwether from Pfizer Inc. (NYSE:PFE), where he was the long-serving greater China regional president and country manager for China at Pfizer Essential Health.

Wu’s move follows BeiGene’s transition into a commercial company last July via a deal for the China commercial operations team from Celgene Corp. (NASDAQ:CELG) and 10 years’ of Chinese rights to multiple myeloma (MM) drug Revlimid lenalidomide and two other cancer drugs (see BioCentury, July 14, 2017)...